These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 39198847

  • 21. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G, Zhu J, Liu F, Yang Y.
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [Abstract] [Full Text] [Related]

  • 22. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.
    Huang Q, Wang Q, Li D, Wei X, Jia Y, Zhang Z, Ai B, Cao X, Guo T, Liao Y.
    J Exp Clin Cancer Res; 2019 Mar 15; 38(1):129. PubMed ID: 30876460
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer.
    Zhang Y, Qian J, Fu Y, Wang Z, Hu W, Zhang J, Wang Y, Guo Y, Chen W, Zhang Y, Wang X, Xie Z, Ye H, Ye F, Zuo Z.
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct 15; 1870(7):167447. PubMed ID: 39089636
    [Abstract] [Full Text] [Related]

  • 24. Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.
    Shen H, Zhu F, Liu J, Xu T, Pei D, Wang R, Qian Y, Li Q, Wang L, Shi Z, Zheng J, Chen Q, Jiang B, Shu Y.
    PLoS One; 2014 Oct 15; 9(7):e103305. PubMed ID: 25058005
    [Abstract] [Full Text] [Related]

  • 25. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
    Han S, Han B, Li Z, Sun D.
    Cell Cycle; 2019 Oct 15; 18(19):2524-2537. PubMed ID: 31416393
    [Abstract] [Full Text] [Related]

  • 26. PHF12 regulates HDAC1 to promote tumorigenesis via EGFR/AKT signaling pathway in non-small cell lung cancer.
    Kong Y, Jiang R, Zhou H, Ge M, Lin H, Wang Y, Yao R, Wang Q, Liang X, Li J, Zhou X.
    J Transl Med; 2024 Jul 29; 22(1):689. PubMed ID: 39075515
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance.
    Xiong R, Sun XX, Wu HR, Xu GW, Wang GX, Sun XH, Xu MQ, Xie MR.
    Thorac Cancer; 2020 Jan 29; 11(1):156-165. PubMed ID: 31777195
    [Abstract] [Full Text] [Related]

  • 33. AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells.
    Kim D, Bach DH, Fan YH, Luu TT, Hong JY, Park HJ, Lee SK.
    Cell Death Dis; 2019 May 01; 10(5):361. PubMed ID: 31043587
    [Abstract] [Full Text] [Related]

  • 34. GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway.
    Wang L, Liu J, Liu J, Chen X, Chang M, Li J, Zhou J, Bai C, Song Y.
    J Cancer Res Clin Oncol; 2019 Apr 01; 145(4):861-872. PubMed ID: 30661098
    [Abstract] [Full Text] [Related]

  • 35. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
    Yiming R, Takeuchi Y, Nishimura T, Li M, Wang Y, Meguro-Horike M, Kohno T, Horike SI, Nakata A, Gotoh N.
    Cancer Sci; 2021 Sep 01; 112(9):3810-3821. PubMed ID: 34145929
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.